-
1دورية أكاديمية
المؤلفون: Cornelis M. van Tilburg, Lindsay B. Kilburn, Sébastien Perreault, Rene Schmidt, Amedeo A. Azizi, Ofelia Cruz-Martínez, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten-van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li-Pen Tsao, Samuel C. Blackman, Peter Manley, Till Milde, Ruth Witt, David T. W. Jones, Darren Hargrave, Olaf Witt
مصطلحات موضوعية: Genetics, Neuroscience, Pharmacology, Cancer, Mental Health, Infectious Diseases, Chemotherapy, First-line, Pediatric low-grade glioma, pLGG, Tovorafenib, Child, BRAF, MAPK
الإتاحة: https://doi.org/10.6084/m9.figshare.25115980.v1Test
https://figshare.com/articles/journal_contribution/Additional_file_1_of_LOGGIC_FIREFLY-2_a_phase_3_randomized_trial_of_tovorafenib_vs_chemotherapy_in_pediatric_and_young_adult_patients_with_newly_diagnosed_low-grade_glioma_harboring_an_activating_RAF_alteration/25115980Test -
2دورية أكاديمية
المؤلفون: Cornelis M. van Tilburg, Lindsay B. Kilburn, Sébastien Perreault, Rene Schmidt, Amedeo A. Azizi, Ofelia Cruz-Martínez, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten-van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li-Pen Tsao, Samuel C. Blackman, Peter Manley, Till Milde, Ruth Witt, David T. W. Jones, Darren Hargrave, Olaf Witt
مصطلحات موضوعية: Genetics, Neuroscience, Pharmacology, Cancer, Mental Health, Infectious Diseases, Chemotherapy, First-line, Pediatric low-grade glioma, pLGG, Tovorafenib, Child, BRAF, MAPK
-
3دورية أكاديمية
المؤلفون: Rasco, Drew W, Medina, Theresa, Corrie, Pippa, Pavlick, Anna C, Middleton, Mark R, Lorigan, Paul, Hebert, Chris, Plummer, Ruth, Larkin, James, Agarwala, Sanjiv S, Daud, Adil I, Qiu, Jiaheng, Bozon, Viviana, Kneissl, Michelle, Barry, Elly, Olszanski, Anthony J
المصدر: Cancer chemotherapy and pharmacology, vol 92, iss 1
مصطلحات موضوعية: Humans, Neoplasms, Melanoma, Skin Neoplasms, Second Primary, Proto-Oncogene Proteins B-raf, Mitogen-Activated Protein Kinase Kinases, Protein Kinase Inhibitors, Maximum Tolerated Dose, Adult, BRAF, Pan-RAF inhibitor, Phase 1, Tovorafenib, Clinical Trials and Supportive Activities, Clinical Research, Cancer, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis
جغرافية الموضوع: 15 - 28
وصف الملف: application/pdf
العلاقة: qt6jq463hg; https://escholarship.org/uc/item/6jq463hgTest; https://escholarship.org/content/qt6jq463hg/qt6jq463hg.pdfTest
الإتاحة: https://doi.org/10.1007/s00280-023-04544-5Test
https://escholarship.org/uc/item/6jq463hgTest
https://escholarship.org/content/qt6jq463hg/qt6jq463hg.pdfTest